CV Therapeutics identifies adenosine A3 receptor agonists with utility in cancer and neutropenia March 24, 2003
DTI-015 affords 40% cure rate and over 400% increase in life span in rats with brain cancer March 20, 2003
Somatostatin analogues and their use in cancer diagnosis and treatment reported by Mallinckrodt March 20, 2003
RSS